SYNLAB AG (VIE:SYAB)

Elevation Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,813	2,509	2,524	5,245	-	-
Market Cap Growth	15.50%	-0.60%	-51.88%	-	-	-
Enterprise Value	4,056	3,846	3,913	6,747	-	-
Last Close Price	12.90	11.41	11.00	22.36	-	-
PE Ratio	31.48	27.19	16.75	8.40	-	-
PS Ratio	1.08	0.95	0.78	1.39	-	-
PB Ratio	1.19	1.07	1.08	2.33	-	-
P/FCF Ratio	9.52	10.59	5.35	6.05	-	-
P/OCF Ratio	6.72	6.91	4.01	5.18	-	-
EV/Sales Ratio	1.55	1.46	1.20	1.79	-	-
EV/EBITDA Ratio	9.18	13.41	6.65	6.33	-	-
EV/EBIT Ratio	26.88	26.99	8.63	7.13	-	-
EV/FCF Ratio	13.73	16.24	8.30	7.78	-	-
Debt / Equity Ratio	0.65	0.67	0.91	0.91	2.61	3.28
Debt / EBITDA Ratio	3.50	3.58	2.90	1.73	4.89	8.84
Debt / FCF Ratio	5.23	6.59	4.49	2.36	7.38	10.76
Asset Turnover	0.53	0.53	0.60	0.70	0.52	0.40
Inventory Turnover	8.63	8.26	8.01	7.28	7.14	10.76
Quick Ratio	1.06	1.03	1.41	1.21	1.82	1.09
Current Ratio	1.24	1.16	1.56	1.37	2.05	1.23
Return on Equity (ROE)	3.81%	3.98%	6.65%	35.29%	3.53%	-11.99%
Return on Assets (ROA)	1.90%	1.77%	5.24%	11.04%	5.41%	2.31%
Return on Capital (ROIC)	2.28%	2.13%	6.48%	13.68%	6.49%	2.71%
Return on Capital Employed (ROCE)	3.80%	3.60%	9.90%	21.20%	9.70%	4.10%
Earnings Yield	3.18%	3.68%	5.97%	11.91%	-	-
FCF Yield	10.51%	9.44%	18.68%	16.53%	-	-
Dividend Yield	-	-	3.00%	1.48%	-	-
Buyback Yield / Dilution	-2.05%	0.41%	-3.09%	84.06%	-0.00%	0.01%
Total Shareholder Return	-	0.41%	-0.09%	85.53%	-0.00%	0.01%

Updated May 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.